A study demonstrates that C3G, a honeysuckle flavonoid, activates PPAR-γ and Nrf2 pathways, reducing oxidative stress and inflammation in HT-29 cells, suggesting their potential as nutraceuticals for managing IBD (206). Here, PPARG is linked to inflammatory bowel disease.